Etiology and genetic features
Lesch-Nyhan syndrome has a clearly defined genetic basis. The disease is inherited as an X-linked recessive trait. Due to this inheritance mechanism, the pathology clinically manifests exclusively in males (only boys are affected).
The root cause of the entire cascade of metabolic disorders is the complete loss of activity of a specific enzyme — hypoxanthine-guanine phosphoribosyltransferase (abbreviated as HGPRT). It is important to emphasize that the absolute absence of this enzyme's activity determines the severity of the disease, distinguishing it from other forms of hyperuricemia.
Biochemical pathogenesis
In a healthy body, the HGPRT enzyme acts as an "economizer", providing the salvage pathway (the so-called "rescue pathway") for purine bases. It captures free purines and returns them to the nucleotide pool so that the cell does not waste resources on synthesizing them from scratch. HGPRT carries out two main reactions:
- Combination of hypoxanthine with phosphoribosyl pyrophosphate (PRPP) to form inosine monophosphate (IMP) and pyrophosphate.
- Combination of guanine with PRPP to form guanosine monophosphate (GMP) and pyrophosphate.
In Lesch-Nyhan syndrome, this salvage pathway is completely blocked. A pathological process develops that strikes metabolism from two sides:
- Substrate accumulation (PRPP). Since PRPP is not consumed in salvage reactions, it accumulates in cells. Excess PRPP acts as a potent stimulator of de novo purine synthesis. As a result, purine production increases manifold.
- Oxidation of unused bases. Free hypoxanthine and guanine that could not be converted into nucleotides are oxidized by the enzyme xanthine oxidase. The end product of this oxidation is uric acid.
Clinical consequences
The double metabolic hit (activation of de novo synthesis and inability to utilize free bases) leads to uric acid being synthesized in enormous, toxic quantities. The most severe form of hyperuricemia develops.
Main manifestations of the syndrome:
- Systemic complications of hyperuricemia: development of gout and formation of urate kidney stones.
- Severe neurotoxicity: the accumulation of metabolites provokes gross neurological and psychiatric abnormalities.
Early diagnosis: The very first clinical sign of the syndrome can be noticed in the first months of the child's life, even before the onset of frightening neurological disorders. Characteristic pink and orange spots appear on the infant's diapers. This phenomenon is due to massive uricosuria: uric acid crystals are excreted in the urine and physically damage the epithelium of the urinary tract, leaving colored stains.
Briefly: answers to topical questions
What medications are used to treat hyperuricemia in Lesch-Nyhan syndrome?
Inhibitors of uric acid formation are used to treat hyperuricemia.
- Allopurinol is a structural analog of hypoxanthine and a competitive inhibitor of the enzyme xanthine oxidase.
As a result of allopurinol administration, uric acid formation decreases. Instead, hypoxanthine and xanthine are excreted, which are more soluble in water and easier for the kidneys to eliminate.
To easily remember the essence of the pathogenesis, use the analogy of a "broken recycling plant": HGPRT enzyme is broken -> purines do not go to secondary processing (salvage) -> all accumulated substrate is burned by xanthine oxidase into "acrid smoke" (uric acid), which poisons the brain and kidneys.
Class and exam questions
Which specific enzyme does not work in Lesch-Nyhan syndrome?
There is a complete absence of hypoxanthine-guanine phosphoribosyltransferase (HGPRT) activity.
Why does the defect in HGPRT enhance de novo purine synthesis?
Due to the blockage of the salvage pathway, phosphoribosyl pyrophosphate (PRPP) is not consumed and accumulates in the cell. Its excess directly activates de novo purine synthesis enzymes.
What symptom allows suspecting the disease in an infant?
The appearance of pink or orange spots on the diapers. These are uric acid crystals that are excreted due to severe hyperuricemia and damage the urinary tract.
What else to study on this topic
- The de novo purine nucleotide synthesis pathway
- The role of xanthine oxidase in metabolism
- Mechanisms of gout development in hyperuricemia
- Causes of neurotoxicity in purine metabolism disorders
Master the entire topic in the "Biochemistry" course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Lesch-Nyhan syndrome" and 3,616 other pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 115 video lessons on the subject
Other topics in the "Nucleotide Metabolism" section
Free video lessons: biochemistryShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.